Application of DBS sampling in combination with LC-MS/MS for pharmacokinetic evaluation of a compound with species-specific blood-to-plasma partitioning.

BACKGROUND Dried blood spot (DBS) sampling in combination with LC-MS/MS has been used increasingly in drug discovery for quantitative analysis to support pharmacokinetic (PK) studies. In this study, we assessed the effect of blood-to-plasma (B:P) partitioning on the bioanalytical performance and PK data acquired by DBS for a compound AMG-1 with species and concentration-dependent B:P ratio. RESULTS B:P partitioning did not adversely affect bioanalytical performance of DBS for AMG-1. For rat, (B:P ratio of 0.63), PK profiles from DBS and plasma methods were comparable. For dog, concentration-dependence of B:P ratio was observed both in vivo and in vitro. Additional studies demonstrated concentration-dependence of the compound's unbound fraction in plasma, which may contribute to the concentration-dependence of the B:P ratio. CONCLUSION DBS is a promising sampling technique for preclinical pharmacokinetic studies. For compounds with high B:P ratio, caution needs to be applied for data comparison and interpretation between matrices.

[1]  Christopher A. James,et al.  Application of automated serial blood sampling and dried blood spot technique with liquid chromatography-tandem mass spectrometry for pharmacokinetic studies in mice. , 2011, Journal of pharmaceutical and biomedical analysis.

[2]  C. James,et al.  Application of automated dried blood spot sampling and LC-MS/MS for pharmacokinetic studies of AMG 517 in rats. , 2011, Bioanalysis.

[3]  A. Chaudhary,et al.  Dried blood spot sampling: coupling bioanalytical feasibility, blood-plasma partitioning and transferability to in vivo preclinical studies. , 2011, Bioanalysis.

[4]  H. Pandya,et al.  Dried blood spots, pharmacokinetic studies and better medicines for children. , 2011, Bioanalysis.

[5]  Elizabeth Thomas,et al.  Evaluation of blood microsampling techniques and sampling sites for the analysis of drugs by HPLC-MS. , 2011, Bioanalysis.

[6]  Peter van Amsterdam,et al.  The application of dried blood spot sampling in global clinical trials. , 2010, Bioanalysis.

[7]  A. Johannessen.  Dried blood spots in HIV monitoring: applications in resource-limited settings. , 2010, Bioanalysis.

[8]  Chester L. Bowen,et al.  Utility of dried blood spot sampling and storage for increased stability of photosensitive compounds. , 2010, Bioanalysis.

[9]  M. Rowland,et al.  Pharmacokinetic considerations as to when to use dried blood spot sampling. , 2010, Bioanalysis.

[10]  N. Spooner,et al.  Effect of storage conditions on the weight and appearance of dried blood spot samples on various cellulose-based substrates. , 2010, Bioanalysis.

[11]  L. Ferrari,et al.  Validation of a high-sensitivity assay for zatebradine in dried blood spots of human blood at pg/ml concentrations using HILIC-MS/MS. , 2010, Bioanalysis.

[12]  Chester L. Bowen,et al.  Application of DBS for quantitative assessment of the peptide Exendin-4; comparison of plasma and DBS method by UHPLC-MS/MS. , 2010, Bioanalysis.

[13]  Neil Spooner,et al.  A glowing future for dried blood spot sampling. , 2010, Bioanalysis.

[14]  T. Olah,et al.  DBS sampling can be used to stabilize prodrugs in drug discovery rodent studies without the addition of esterase inhibitors. , 2010, Bioanalysis.

[15]  Neil Spooner,et al.  The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs. , 2010, Bioanalysis.

[16]  M. Barfield,et al.  Application of the DBS methodology to a toxicokinetic study in rats and transferability of analysis between bioanalytical laboratories. , 2010, Bioanalysis.

[17]  M. Bayliss,et al.  Utilization of DBS within drug discovery: development of a serial microsampling pharmacokinetic study in mice. , 2010, Bioanalysis.

[18]  Xi Chen,et al.  Human DBS sampling with LC-MS/MS for enantioselective determination of metoprolol and its metabolite O-desmethyl metoprolol. , 2010, Bioanalysis.

[19]  P. Abu-Rabie,et al.  Study to assess the effect of age of control human and animal blood on its suitability for use in quantitative bioanalytical DBS methods. , 2010, Bioanalysis.

[20]  H. Pandya,et al.  Facilitating pharmacokinetic studies in children: a new use of dried blood spots , 2010, Archives of Disease in Childhood.

[21]  M. Rowland,et al.  Use of Dried Blood Spots in Drug Development: Pharmacokinetic Considerations , 2010, The AAPS Journal.

[22]  J. McElnay,et al.  Development and validation of a dried blood spot-LC-APCI-MS assay for estimation of canrenone in paediatric samples. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[23]  Wenkui Li,et al.  Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. , 2010, Biomedical chromatography : BMC.

[24]  L. Stolk,et al.  Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry. , 2009, Journal of pharmaceutical and biomedical analysis.

[25]  C. Damen,et al.  Application of dried blood spots combined with high-performance liquid chromatography coupled with electrospray ionisation tandem mass spectrometry for simultaneous quantification of vincristine and actinomycin-D , 2009, Analytical and bioanalytical chemistry.

[26]  M. Barfield,et al.  Study of dried blood spots technique for the determination of dextromethorphan and its metabolite dextrorphan in human whole blood by LC-MS/MS. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[27]  M. Barfield,et al.  Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method. , 2009, Analytical chemistry.

[28]  W. Stevens,et al.  Performance of a Novel Human Immunodeficiency Virus (HIV) Type 1 Total Nucleic Acid-Based Real-Time PCR Assay Using Whole Blood and Dried Blood Spots for Diagnosis of HIV in Infants , 2008, Journal of Clinical Microbiology.

[29]  Neil Spooner,et al.  Application of dried blood spots combined with HPLC-MS/MS for the quantification of acetaminophen in toxicokinetic studies. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[30]  H. Q. Le,et al.  Enzyme-linked immunoassay for dengue virus IgM and IgG antibodies in serum and filter paper blood , 2006, BMC infectious diseases.

[31]  Shelly X. Li,et al.  A novel liquid chromatography/tandem mass spectrometry based depletion method for measuring red blood cell partitioning of pharmaceutical compounds in drug discovery. , 2005, Rapid communications in mass spectrometry : RCM.

[32]  F. Bowling,et al.  Development of a protocol for newborn screening for disorders of the galactose metabolic pathway , 1986, Journal of Inherited Metabolic Disease.

[33]  E. Naylor,et al.  The use of filter paper-dried blood spots for thyroid-antibody screening in adults. , 2004, The Journal of laboratory and clinical medicine.

[34]  Kevin P Bateman,et al.  Discovery stage pharmacokinetics using dried blood spots. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[35]  L. Ilona,et al.  Detection of herpes simplex virus DNA in dried blood spots making a retrospective diagnosis possible , 2003 .

[36]  A. McLachlan,et al.  Validation of methods to study the distribution and protein binding of tacrolimus in human blood. , 2001, Journal of pharmacological and toxicological methods.

[37]  S. Parker,et al.  The use of the dried blood spot sample in epidemiological studies. , 1999, Journal of clinical pathology.

[38]  R. Guthrie,et al.  A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS. , 1963, Pediatrics.